GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moogene Medi Co Ltd (XKRX:322970) » Definitions » Debt-to-EBITDA

Moogene Medi Co (XKRX:322970) Debt-to-EBITDA : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Moogene Medi Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Moogene Medi Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. Moogene Medi Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. Moogene Medi Co's annualized EBITDA for the quarter that ended in . 20 was ₩0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Moogene Medi Co's Debt-to-EBITDA or its related term are showing as below:

XKRX:322970's Debt-to-EBITDA is not ranked *
in the Biotechnology industry.
Industry Median: 1.36
* Ranked among companies with meaningful Debt-to-EBITDA only.

Moogene Medi Co Debt-to-EBITDA Historical Data

The historical data trend for Moogene Medi Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moogene Medi Co Debt-to-EBITDA Chart

Moogene Medi Co Annual Data
Trend
Debt-to-EBITDA

Moogene Medi Co Semi-Annual Data
Debt-to-EBITDA

Competitive Comparison of Moogene Medi Co's Debt-to-EBITDA

For the Biotechnology subindustry, Moogene Medi Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moogene Medi Co's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moogene Medi Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Moogene Medi Co's Debt-to-EBITDA falls into.


;
;

Moogene Medi Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Moogene Medi Co's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Moogene Medi Co's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (. 20) EBITDA data.


Moogene Medi Co  (XKRX:322970) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Moogene Medi Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Moogene Medi Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Moogene Medi Co Business Description

Traded in Other Exchanges
N/A
Address
670, Daewangpangyo-ro, Bundang-gu, U-space 2 A-505, Gyeonggi-do, Seongnam-si, KOR
Moogene Medi Co Ltd is a bio-technology company engaged in gene therapy and nano-materials fabrication using cutting-edge nanotechnologies. The company has developed programs to monitor KRAS-mutant cancer strains, androgenic alopecia, type two diabetes, and liver diseases.

Moogene Medi Co Headlines

No Headlines